Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | 5'-nucleotidase, ecto (CD73) | References | |
Bos taurus | Intestinal alkaline phosphatase | References | |
Rattus norvegicus | 5'-nucleotidase | References | |
Bos taurus | Alkaline phosphatase, tissue-nonspecific isozyme | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | alkaline phosphatase | 0.0393 | 1 | 0.5 |
Echinococcus multilocularis | alkaline phosphatase | 0.0393 | 1 | 0.5 |
Echinococcus multilocularis | intestinal type alkaline phosphatase | 0.0393 | 1 | 0.5 |
Schistosoma mansoni | 23-cyclic-nucleotide 2-phosphodiesterase | 0.0335 | 0.7728 | 0.693 |
Schistosoma mansoni | 23-cyclic-nucleotide 2-phosphodiesterase | 0.0334 | 0.769 | 0.6879 |
Echinococcus multilocularis | alkaline phosphatase, intestinal, gene 2 | 0.0393 | 1 | 0.5 |
Echinococcus granulosus | intestinal type alkaline phosphatase 1 | 0.0393 | 1 | 0.5 |
Echinococcus granulosus | alkaline phosphatase intestinal gene 2 | 0.0393 | 1 | 0.5 |
Treponema pallidum | 5'-nucleotidase (ushA) | 0.0335 | 0.7728 | 0.5 |
Toxoplasma gondii | 5'-nucleotidase, C-terminal domain-containing protein | 0.0335 | 0.7728 | 1 |
Schistosoma mansoni | alkaline phosphatase | 0.0393 | 1 | 1 |
Schistosoma mansoni | alkaline phosphatase | 0.0393 | 1 | 1 |
Echinococcus multilocularis | intestinal type alkaline phosphatase 1 | 0.0393 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.88 uM | Inhibition of human Ecto-5'-nucleotidase transfected in COS7 cells preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
IC50 (binding) | = 1.84 uM | Inhibition of rat Ecto-5'-nucleotidase transfected in COS7 cells preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
IC50 (binding) | = 5.36 uM | Inhibition of bovine tissue non-specific alkaline phosphatase preincubated for 3 to 5 mins followed by CDP-star substrate addition measured after 15 mins by luminescence assay | ChEMBL. | 27054295 |
IC50 (binding) | = 9.87 uM | Inhibition of calf intestinal alkaline phosphatase preincubated for 3 to 5 mins followed by CDP-star substrate addition measured after 15 mins by luminescence assay | ChEMBL. | 27054295 |
Ki (binding) | = 0.042 uM | Inhibition of human Ecto-5'-nucleotidase transfected in COS7 cells preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
Ki (binding) | = 0.087 uM | Inhibition of rat Ecto-5'-nucleotidase transfected in COS7 cells preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
Ki (binding) | = 2.28 uM | Inhibition of bovine tissue non-specific alkaline phosphatase preincubated for 3 to 5 mins followed by CDP-star substrate addition measured after 15 mins by luminescence assay | ChEMBL. | 27054295 |
Ki (binding) | = 4.21 uM | Inhibition of calf intestinal alkaline phosphatase preincubated for 3 to 5 mins followed by CDP-star substrate addition measured after 15 mins by luminescence assay | ChEMBL. | 27054295 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.